Cinacalcet 30 mg Tablet PCD Franchise, Hyperparathyroidism Tablet Supplier India, Cinacalcet Tablet Manufacturer, Parathyroid Disorder Tablet Distributor, Best Price Pharma Franchise

Name: Cinacalcet 30 mg Tablet | Hyperparathyroidism Management | Cinaclat
Brand: Cinaclat 30 Tablet
Rating: 4.8 (150 reviews)

Cinacalcet Tablet Franchise in Ahmedabad

Cinaclat 30 mg Tablet Supplier in Mumbai

Cinacalcet Tablet Manufacturer in Bangalore

Cinacalcet Tablet Exporter in Chandigarh

Home/Products /cinacalcet-30mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Cinacalcet Tablet for Hyperparathyroidism Best Price

Cinacalcet 30 mg Tablet Manufacturer India

Cinacalcet Tablet for Calcium & PTH Control

Cinaclat 30 Tablet

Composition : Cinacalcet (30mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Cinaclat 30 Tablet contains Cinacalcet 30 mg, a calcimimetic agent used to manage secondary hyperparathyroidism in chronic kidney disease (CKD) patients on dialysis and parathyroid carcinoma. It works by increasing the sensitivity of calcium-sensing receptors on parathyroid glands, reducing parathyroid hormone (PTH) secretion and controlling calcium levels.

This therapy helps in preventing bone complications, vascular calcifications, and hypercalcemia, which are common in CKD patients. Cinacalcet is particularly valuable for patients who cannot achieve target PTH levels with standard therapy alone.

Clinically, Cinaclat 30 Tablet is indicated for secondary hyperparathyroidism, parathyroid carcinoma, and associated metabolic disorders, providing effective calcium and phosphate balance.

The tablet offers precise dosing, easy oral administration, and consistent clinical effect, making it suitable for hospital, dialysis, and long-term patient care settings.

About the Product

Clinically, Cinaclat 30 Tablet is indicated for secondary hyperparathyroidism, parathyroid carcinoma, and associated metabolic disorders, providing effective calcium and phosphate balance.

The tablet offers precise dosing, easy oral administration, and consistent clinical effect, making it suitable for hospital, dialysis, and long-term patient care settings.

Common side effects may include nausea, vomiting, hypocalcemia, headache, and dizziness. Rarely, allergic reactions, muscle cramps, or severe hypocalcemia may occur.

Cinaclat 30 Tablet is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and for management of hypercalcemia in patients with parathyroid carcinoma. It helps maintain mineral balance and prevent bone and cardiovascular complications.

Use Cinaclat 30 Tablet strictly under the guidance of a healthcare professional. Regular monitoring of serum calcium, phosphate, and PTH levels is essential. Inform your doctor if you have a history of hypocalcemia, heart rhythm disorders, or gastrointestinal issues. Seek immediate medical attention if severe muscle cramps, numbness, or irregular heartbeat occurs.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use beyond the expiry date.